MOTIVATION: Early-stage drug discovery relies on testing compounds across a limited set of cell lines, making it challenging to capture biological diversity while maintaining experimental efficiency. Current predictive approaches for identifying responsive cell lines often depend on high-dimensional omics data, which can be costly and difficult to interpret. We therefore evaluated whether drug-response panel (DRP) descriptors, which capture sensitivity profiles to a reference set of compounds, can provide an efficient and informative alternative for modelling drug response in cell lines. RESULTS: Using gradient boosting models across GDSC and CCLE datasets, DRP descriptors consistently outperformed mRNA expression features in predicting drug sensitivity (-log10(IC50)), although performance varied across compounds. DRP-guided cell line selection enabled downstream omics-based modelling that recovered known MAPK-associated sensitivity signatures and identified potential biomarkers for MEK1/2 and BTK/MNK inhibitors. Extending this framework, we demonstrated its utility in compound prioritisation by distinguishing between tumourigenic MCF7 and non-tumourigenic MCF10A cells, successfully identifying compounds with selective activity. Together, these results show that DRP-based representations, derived from compact screening panels, support efficient cell line selection, biomarker discovery, and compound prioritisation in early-stage drug development. AVAILABILITY: Code and data uploaded to https://github.com/abbiAR/-Strategic-Cell-Line-and-Compound-Selection-Using-Drug-Response-Profiles.

MOTIVATION: Molecular docking is a commonly used approach for estimating binding conformations and their resultant binding affinities. Machine learning has been successfully deployed to enhance such affinity estimations. Many methods of varying complexity have been developed making use of some or all the spatial and categorical information available in these structures. The evaluation of such methods has mainly been carried out using datasets from PDBbind. Particularly the Comparative Assessment of Scoring Functions (CASF) 2007, 2013, and 2016 datasets with dedicated test sets. This work demonstrates that only a small number of simple descriptors is necessary to efficiently estimate binding affinity for these complexes without the need to know the exact binding conformation of a ligand. RESULTS: The developed approach of using a small number of ligand and protein descriptors in conjunction with gradient boosting trees demonstrates high performance on the CASF datasets. This includes the commonly used benchmark CASF2016 where it appears to perform better than any other approach. This methodology is also useful for datasets where the spatial relationship between the ligand and protein is unknown as demonstrated using a large ChEMBL-derived dataset. AVAILABILITY AND IMPLEMENTATION: Code and data uploaded to https://github.com/abbiAR/PLBAffinity.

SUMMARY: Recently, several new contact prediction methods have been published. They use (i) large sets of multiple aligned sequences and (ii) assume that correlations between columns in these alignments can be the results of indirect interaction. These methods are clearly superior to earlier methods when it comes to predicting contacts in proteins. Here, we demonstrate that combining predictions from two prediction methods, PSICOV and plmDCA, and two alignment methods, HHblits and jackhmmer at four different e-value cut-offs, provides a relative improvement of 20% in comparison with the best single method, exceeding 70% correct predictions for one contact prediction per residue. AVAILABILITY: The source code for PconsC along with supplementary data is freely available at http://c.pcons.net/ CONTACT: [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.